These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20823152)

  • 1. Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity.
    Hartman ZC; Osada T; Glass O; Yang XY; Lei GJ; Lyerly HK; Clay TM
    Cancer Res; 2010 Sep; 70(18):7209-20. PubMed ID: 20823152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways.
    Zhu J; Huang X; Yang Y
    J Virol; 2007 Apr; 81(7):3170-80. PubMed ID: 17229689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
    Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
    Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating vaccinia virus cytokine co-expression in TLR GKO mice.
    Sutherland DB; Ranasinghe C; Regner M; Phipps S; Matthaei KI; Day SL; Ramshaw IA
    Immunol Cell Biol; 2011 Aug; 89(6):706-15. PubMed ID: 21173782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors.
    Yamaguchi T; Kawabata K; Koizumi N; Sakurai F; Nakashima K; Sakurai H; Sasaki T; Okada N; Yamanishi K; Mizuguchi H
    Hum Gene Ther; 2007 Aug; 18(8):753-62. PubMed ID: 17685831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral Responses Elicited by Adenovirus Displaying Epitopes Are Induced Independently of the Infection Process and Shaped by the Toll-Like Receptor/MyD88 Pathway.
    Anchim A; Raddi N; Zig L; Perrieau P; Le Goffic R; Ryffel B; Benihoud K
    Front Immunol; 2018; 9():124. PubMed ID: 29459860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus vector-mediated in vivo gene transfer of OX40 ligand to tumor cells enhances antitumor immunity of tumor-bearing hosts.
    Andarini S; Kikuchi T; Nukiwa M; Pradono P; Suzuki T; Ohkouchi S; Inoue A; Maemondo M; Ishii N; Saijo Y; Sugamura K; Nukiwa T
    Cancer Res; 2004 May; 64(9):3281-7. PubMed ID: 15126371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo.
    Warger T; Osterloh P; Rechtsteiner G; Fassbender M; Heib V; Schmid B; Schmitt E; Schild H; Radsak MP
    Blood; 2006 Jul; 108(2):544-50. PubMed ID: 16537810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms.
    Hou B; Reizis B; DeFranco AL
    Immunity; 2008 Aug; 29(2):272-82. PubMed ID: 18656388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of IFN-γ by splenic dendritic cells during innate immune responses against Francisella tularensis LVS depends on MyD88, but not TLR2, TLR4, or TLR9.
    De Pascalis R; Rossi AP; Mittereder L; Takeda K; Akue A; Kurtz SL; Elkins KL
    PLoS One; 2020; 15(8):e0237034. PubMed ID: 32745117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy.
    Narayanan P; Lapteva N; Seethammagari M; Levitt JM; Slawin KM; Spencer DM
    J Clin Invest; 2011 Apr; 121(4):1524-34. PubMed ID: 21383499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigens.
    Geng D; Zheng L; Srivastava R; Velasco-Gonzalez C; Riker A; Markovic SN; Davila E
    Cancer Res; 2010 Oct; 70(19):7442-54. PubMed ID: 20807806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
    Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
    Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors.
    Rhee EG; Blattman JN; Kasturi SP; Kelley RP; Kaufman DR; Lynch DM; La Porte A; Simmons NL; Clark SL; Pulendran B; Greenberg PD; Barouch DH
    J Virol; 2011 Jan; 85(1):315-23. PubMed ID: 20962088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of adaptive immunity by flagellin does not require robust activation of innate immunity.
    Sanders CJ; Franchi L; Yarovinsky F; Uematsu S; Akira S; Núñez G; Gewirtz AT
    Eur J Immunol; 2009 Feb; 39(2):359-71. PubMed ID: 19152336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.
    Kaisho T; Hoshino K; Iwabe T; Takeuchi O; Yasui T; Akira S
    Int Immunol; 2002 Jul; 14(7):695-700. PubMed ID: 12096028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell specific targeting of MyD88 signalling pathways in vivo.
    Arnold-Schrauf C; Berod L; Sparwasser T
    Eur J Immunol; 2015 Jan; 45(1):32-9. PubMed ID: 25403892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of contact sensitivity in non-obese diabetic (NOD) mice by innate immunity.
    Szczepanik M; Majewska-Szczepanik M; Wong FS; Kowalczyk P; Pasare C; Wen L
    Contact Dermatitis; 2018 Oct; 79(4):197-207. PubMed ID: 29943459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus.
    Suzuki M; Cerullo V; Bertin TK; Cela R; Clarke C; Guenther M; Brunetti-Pierri N; Lee B
    Hum Gene Ther; 2010 Mar; 21(3):325-36. PubMed ID: 19824822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.